Martin Shkreli

Who / What

Martin Shkreli is an American investor and businessman known for his involvement in hedge funds and pharmaceutical companies.

Background & History

Born on March 17, 1983, Shkreli co‑founded the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare. He also co‑founded and served as CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and later became the CEO of the start‑up software company Gödel Systems, which he founded in August 2016. His career spans finance, pharmaceuticals, and technology.

Why Notable

Shkreli’s notoriety rose when Turing Pharmaceuticals raised the price of the antiparasitic drug Daraprim from $13.50 to $750 per pill in September 2015. The move triggered a global scandal and earned him the label “the most hated man in America.” His actions highlighted issues of drug pricing and corporate ethics.

In the News

Shkreli remains a figure of public interest due to legal proceedings, including a 2015 drug‑price hike controversy and subsequent criminal charges. Recent coverage often focuses on the legal outcomes and his influence on pharmaceutical industry regulation.

Key Facts

Type: person

Also known as: Martin Shkreli

Founded / Born: 1983 – New York City, New York, U.S.

Key dates: March 17, 1983 (birth); September 2015 (Daraprim price hike); August 2016 (founder of Gödel Systems)

Geography: United States

Affiliation: Elea Capital, MSMB Capital Management, MSMB Healthcare, Retrophin, Turing Pharmaceuticals, Gödel Systems

Links

[Wikipedia](https://en.wikipedia.org/wiki/Martin_Shkreli)

Sources

• 🔗 Wikipedia

Martin Shkreli (; born March 17, 1983) is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016. In September 2015, Shkreli was widely criticized when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price to insurance companies from $13.50 to $750.00 (USD) per pill, sparking a scandal in the United States and around the world, cementing his reputation as the 'the most hated man in America'.